OncoMed Pharmaceuticals, Inc. to Ring The NASDAQ Stock

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
OncoMed Pharmaceuticals, Inc. [OMED] to Ring The NASDAQ Stock Market Closing Bell

ADVISORY, Feb. 7, 2014 (GLOBE NEWSWIRE) --

What:

OncoMed Pharmaceuticals, Inc. [OMED], a clinical-stage company developing novel therapeutics that target cancer stem cells (CSCs), or tumor-initiating cells, will visit the NASDAQ MarketSite in Times Square.

In honor of the occasion, Paul J. Hastings, Chairman & CEO, will ring the Closing Bell.

Where:

NASDAQ MarketSite – 4 Times Square – 43 rd & Broadway – Broadcast Studio

When:

Monday, February 10, 2014 – 3:45 p.m. to 4:00 p.m. ET

Contact :

Shari Annes
(650) 888-0902
Shari.annes@oncomed.com

NASDAQ MarketSite:
Christine Barna
(646) 441-5310
Christine.Barna@nasdaqomx.com

Feed Information:

Fiber Line (Encompass Waterfront): 4463

Gal 3C/06C 95.05 degrees West
18 mhz Lower
DL 3811 Vertical
FEC 3/4
SR 13.235
DR 18.295411
MOD 4:2:0
DVBS QPSK

Social Media:

For multimedia features such as exclusive content, photo postings, status updates and video of bell ceremonies please visit our Facebook page at: http://www.facebook.com/NASDAQ .

For photos from ceremonies and events visit our Instagram Page: http://instagram.com/nasdaq

For news tweets, please visit our Twitter page at: http://twitter.com/nasdaqomx

For exciting viral content and ceremony photos visit our Tumblr Page: http://nasdaq.tumblr.com/

Webcast:

A LiveStream of the NASDAQ Closing Bell will be available at: https://new.livestream.com/nasdaq/live

Or

http://www.nasdaq.com/about/marketsitetowervideo.asx

Photos:

To obtain a hi-resolution photograph of the Market Close, please go to http://www.nasdaq.com/reference/marketsite_events.stm and click on the market close of your choice.                             

About OncoMed Pharmaceuticals, Inc. [OMED]:

OncoMed Pharmaceuticals is a clinical-stage company focused on discovering and developing novel therapeutics targeting cancer stem cells (CSC). OncoMed has five anti-cancer product candidates in clinical development, including demcizumab (Anti-DLL4, OMP-21M18), OMP-59R5 (Anti-Notch2/3), OMP-52M51 (Anti-Notch1), vantictumab (Anti-Fzd7, OMP-18R5), and OMP-54F28 (Fzd8-Fc), which target key cancer stem cell signaling pathways including Notch and Wnt. OncoMed has two other antibodies in preclinical development, Anti-DLL4/Anti-VEGF bispecific and Anti-RSPO3, with Investigational New Drug filings planned for late 2014 or early 2015. OncoMed is also pursuing discovery of additional novel anti-CSC product candidates. OncoMed has formed strategic alliances with Celgene Corporation, Bayer Pharma AG and GlaxoSmithKline (GSK). Additional information can be found at the company's website: www.oncomed.com .

About NASDAQ OMX Group:

NASDAQ OMX (Nasdaq: NDAQ ) is a leading provider of trading, exchange technology, information and public company services across six continents. Through its diverse portfolio of solutions, NASDAQ OMX enables customers to plan, optimize and execute their business vision with confidence, using proven technologies that provide transparency and insight for navigating today's global capital markets. As the creator of the world's first electronic stock market, its technology powers more than 80 marketplaces in 50 countries, and approximately 1 in 10 of the world's securities transactions. NASDAQ OMX is home to more than 3,300 listed companies with a market value of over $7 trillion and more than 10,000 corporate clients. To learn more, visit www.nasdaqomx.com .

-NDAQA-

Scroll down for more posts ▼

Top 10 Most Recent News Articles

JumpCloud Tackles Compliance in the AI Era

Updated Category News Views 131

Compliance in a Changing Tech Landscape JumpCloud's stepping up in this brave new world riddled with tech and AI agents. They've got fresh platform features in their arsenal that'll keep organizations audit-ready day in and day out. Now, if you think compliance is just for the accountants to fret over, think again. In the agentic era, these advanced marvels—AI agents...

Continue Reading
Study Reveals Stark Disparities in Education Equity

Updated Category News Views 5

Are We Dropping the Ball on Future Talent? Listen, there’s a harsh truth screaming at us from the NWEA’s latest study, and it’s not pretty. We’re talking about a serious gap here, folks—one that shows lower-income kids are getting the short end of the stick in education yet again. When more than half of U.S. students come from lower-income families but only 20%...

Continue Reading
2026 Global Ocean Forum Unveils Key Marine Strategies

Updated Category News Views 34

Riding the Waves in Qingdao It ain't every day that a talk-fest dedicated to oceans gets my attention, but when the Global Ocean Development Forum plants its flag in Qingdao, even I sit up. We're talking about some real fireworks in the marine economy sector with this gig's '1+1+4+8' framework. Now, before you scratch your head on the bingo numbers—it's the opening...

Continue Reading
Quad Sees Marginal Gains Amid Industry Challenges

Updated Category News Views 63

Treading Water with a Splash of Strategic Moves When you're in the thick of market shifts, sometimes it's not about big leaps but staying afloat with purpose. That's what Quad's recent financial release seems to hint at. A steady net sales figure hovering at $587 million for Q3 2026, barely a nudge compared to last year's numbers, sets the tone. It's not the fireworks...

Continue Reading
Federal Signal Acquires GVS, Boosts Vacuum Truck Lineup

Updated Category News Views 46

Federal Signal's Latest Move in Vacuum Truck Arena A shakeup in the vacuum truck market? You bet. Federal Signal Corporation has made waves yet again by acquiring the lion's share of Global Vacuum Systems (GVS) assets and operations. We're talking a transaction valued at a hefty $29 million. Dishing Out the Dollars and Cents Now, what stirs the pot in this deal is the...

Continue Reading
Personalized Senior Living Guidance Finds Home in South Jersey

Updated Category News Views 66

Shaunique Adams and Her Mission in South Jersey In a world where compassion sometimes feels like it's on short supply, Shaunique Adams is making sure it's at the forefront of her mission. Having experienced the emotional whirlwind of caregiving firsthand, Adams has transformed her personal journey into a mission to serve families navigating similar paths. Through Trua...

Continue Reading
Civitas Boosts Orlando Luxury Hotel with $386M Loan

Updated Category News Views 33

Orlando Sets the Stage for Luxury Expansion Well, it seems Orlando's hospitality scene is about to get a significant bump. Civitas Capital Group just tossed a cool $386 million into the pot for the construction of a 700-key luxury hotel on the infamous International Drive. We're not talking about just another hotel here; this one's a real beast, a future InterContinental...

Continue Reading
Nikon Unveils Game-Changing Zoom Lens for Pros

Updated Category News Views 35

Nikon Raises the Bar with New Pro Zoom Lens Well, Nikon's done it again, folks. They've dropped the NIKKOR Z 120-300mm f/2.8 TC VR S lens, and it looks like they're giving photographers something to drool over. Now, before you start rolling your eyes, this isn't just another shiny gadget. This bad boy is lighter and faster than anything Nikon's thrown at us before, and it...

Continue Reading
E. Coli Outbreaks Spark Push for New Petting Zoo Laws

Updated Category News Views 0

A Long-Standing Question Finally Answered There comes a time when asking the same question repeatedly feels like chasing your own tail. That's where Bill Marler, food safety attorney extraordinaire, found himself after two decades of wondering if petting zoos should face the chopping block. Right on the heels of E. coli investigations across Illinois, California, and...

Continue Reading
Savvas Launches Miller & Levine Biology Program Revamp

Updated Category News Views 35

Education Meets Innovation: Savvas Takes a Bold Step Who would have thought biology education could get a makeover that might actually stick? Savvas Learning Company thinks it's onto something with the launch of the all-new Miller & Levine Experience Biology Program. The spotlight's on innovation—it's about time someone shook up the way high schoolers learn biology. A...

Continue Reading

Top 5 Most Recently Viewed Articles

Neuboron Medical Group Sets the Stage for Cancer Treatment Innovation

Updated Category News Views 208

Introduction to Neuboron Medical Group's Innovations Neuboron Medical Group is at the forefront of revolutionizing cancer treatment through its advanced use of Boron Neutron Capture Therapy (BNCT). This technology has gained momentum worldwide, and Neuboron is making significant strides with the creation of China's first accelerator-based BNCT demonstration center in...

Continue Reading
European Market Update: Mixed Results in French Trading Session

Updated Category News Views 141

As the trading session wrapped up in France, it was clear: the stock market painted a pretty chaotic picture. The CAC 40 index took a hit, dropping by 2.00%. Meanwhile, the SBF 120 index managed to climb a bit, up by 0.66%. This kind of mixed performance suggests investors were split—some panicking while others sniffed out opportunities in the mayhem. CAC 40 Drama: Top...

Continue Reading
Man Group Reports Key Position Details in Darktrace Acquisition

Updated Category News Views 105

Man Group’s Position Disclosure Regarding Darktrace Man Group PLC has recently published a notable disclosure concerning its interests in Darktrace plc, which has sparked interest among investors and market analysts. This move complies with Rule 8.3 of the Takeover Code, which requires transparency about positions in relevant securities. Let’s take a closer look at...

Continue Reading
Apollo's Strategic Fund Closure Signals Confidence in Credit Markets

Updated Category News Views 238

Apollo's Strategic Fund Closure Signals Confidence in Credit Markets In a bold move that reflects confidence in the evolving financial landscape, Apollo recently closed on $8.5 billion in total commitments for its Accord+ strategy. This remarkable achievement includes a significant $4.8 billion earmarked for the Accord+ Fund II, demonstrating not only robust investor...

Continue Reading
Perseus Mining's Bold Move to Purchase Predictive Discovery

Updated Category News Views 231

Perseus Mining Makes a Strategic Move with Predictive Discovery Perseus Mining Limited (ASX/TSX: PRU) has announced an exciting proposal to acquire Predictive Discovery Limited (ASX: PDI), a bold step that highlights its commitment to growth in the mining sector. This proposed acquisition involves a definitive binding offer for all issued shares in Predictive Discovery...

Continue Reading